Results 81 to 90 of about 1,651 (123)

The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by <i>Enterococcus</i> spp. [PDF]

Open Forum Infect Dis
Frondizi F, Leanza GM, Chiuchiarelli M, Catania F, Sangiorgi F, Giovannenze F, Taddei E, Tamburrini E, Torti C, Scoppettuolo G.   +9 more
europepmc   +1 more source

Are Oritavancin and Dalbavancin More Cost Effective for Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Medical Center? [PDF]

Fed Pract
Hanks D, Jodlowski TZ, Madaras-Kelly K, Diaz J, Vietri N.   +4 more
europepmc   +1 more source

Oritavancin for the Treatment of <i>Staphylococcus aureus</i> Bacteremia-A Retrospective Single-arm Cohort Study. [PDF]

Open Forum Infect Dis
Jordan H, Kozierowski K, Pickles R, Davis JS.   +3 more
europepmc   +1 more source

Current Recommendations, Antibiotic Resistance, and Emerging Treatments for Gram-Positive Ocular Infections in the United States. [PDF]

Antibiotics (Basel)
Fenniri I, André C.
europepmc   +1 more source

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil. [PDF]

Open Forum Infect Dis
Stohs EJ, Alexander BT, Fey PD, Foreman MCL, Xu L, Penewit K, Waalkes A, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

Understanding Daptomycin Resistance Mechanisms and Treatment Challenges in <i>Enterococcus faecium</i> Infection: A Case Series. [PDF]

Antibiotics (Basel)
Nair-Collins S, Godart G, Patel N, Yadav V, Larimore K, LeGout JD, Chitale R, Durvasula R, Oring J.   +8 more
europepmc   +1 more source

Antimicrobial Resistance in Major Gram-Positive Pathogens: Beyond the Vancomycin Border. [PDF]

Antibiotics (Basel)
Papageorgiou D, Akinosoglou K.
europepmc   +1 more source

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Drugs - Real World Outcomes, 2020
doaj   +1 more source

CORR Insights®: Can Oritavancin Be Used for Treatment and/or Suppressive Antimicrobial Therapy of Bone and Joint Infections Caused by Vancomycin-resistant Enterococcus faecium ? [PDF]

Clin Orthop Relat Res
Webb ML.
europepmc   +1 more source

Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections. [PDF]

Antimicrob Agents Chemother
Turner AM, Kinsella P, Miller WR, Carter GP, Tran TT, Howden BP, Arias CA.   +6 more
europepmc   +1 more source